DEN250013 is the FDA 510(k) clearance record for Modius Spero, a class II device, cleared for Neurovalens Limited on under FDA product code SHX (Transcranial Nerve Stimulation Device For The Treatment Of Post-Traumatic Stress Disorder Associated Symptoms). FDA's definition for product code SHX reads: "A transcranial nerve stimulation device for the treatment of post-traumatic stress disorder (PTSD) associated symptoms is a prescription, home-use, externally worn device that applies electrical stimulation to a location on the patient’s...". FDA records list 4 510(k) clearances for Neurovalens Limited, from to . As of , FDA records show no recalls naming DEN250013.
Clearance record
- Decision date
- Received
- (387 days to decision)
- Product code
- SHX Transcranial Nerve Stimulation Device For The Treatment Of Post-Traumatic Stress Disorder Associated Symptoms
- Regulation
- 21 CFR 882.5807
- Device class
- Class II
- Review panel
- Neurology
- Applicant
- Neurovalens Limited 8 Carmagrim Rd., Portglenone, GB
- Third party review
- No
Clearances, product code SHX
Trailing 12 monthsShow the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 1 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
